Why, doesn't vaccinating the elderly protect the elderly?  - SM

 

http://www.vaccinebulletin.com/145/spot145.html

 

 

 

Spotlight

 

 


VACCINATING SCHOOLCHILDREN AGAINST INFLUENZA TO PROTECT THE ELDERLY

 

inter season deaths in the elderly can be prevented by vaccinating schoolchildren against influenza, according to a recent study. Historically, Japan is the only country that has ever based its influenza control policy on the vaccination of schoolchildren rather than elderly persons. Special programs of vaccination against influenza for schoolchildren were initiated in 1962, and legislation enacted in 1977 made influenza vaccination obligatory for this group. In 1987, however, new legislation permitted parents to refuse influenza vaccination of their children, and in 1994, the program of immunizing schoolchildren against influenza was discontinued.
     Recently, a team of experts in influenza epidemiology, mortality and morbidity, and vaccine usage from Japan and the United States analyzed data on all-cause mortality and that attributed to pneumonia and influenza in the two countries, as well as census data and statistics on the rates of vaccination, for 1949 through 1998 (N Engl J Med. 2001;344:889-896). The study was undertaken to determine whether a reduction in excess mortality occurred during winter influenza seasons in Japan during the years in which high rates of influenza vaccination were reported in schoolchildren.
      The excess mortality from pneumonia and influenza, as well as mortality from all causes, was highly correlated and similarly proportional in each country, according to principal investigator Thomas A. Reichert, PhD, MD, formerly of Becton Dickinson and now at the consulting firm of Entropy Limited in Lincoln, Massachusetts. Whereas in the United States these rates were nearly constant over time, excess mortality rates in Japan dropped from values three to four times those in the United States to values similar to those in the United States when influenza vaccination in schoolchildren was implemented. The vaccination of Japanese schoolchildren prevented an estimated 37,000 to 49,000 deaths per year—about one death for every 420 schoolchildren vaccinated. This became clear only when the vaccination of schoolchildren was discontinued and the excess mortality rates in Japan rose. Whereas the number of excess deaths during the winter season in Japan declined from 1962 until 1987, in spite of a large increase in the number of elderly persons, the number of excess deaths began to climb after 1987, and the increase became quite rapid after 1994.
      “The most likely explanation for this changing pattern of seasonal mortality is that the herd immunity produced by mass immunization of schoolchildren protected elderly persons,” the investigators wrote. Other factors considered include improvements in the social infrastructure and health care as well as technological advances and changes in social custom, which occurred during the period when excess mortality declined and then began to rise.
      In preschool children, live attenuated influenza vaccine has been shown to provide about 90% protection against influenza-induced illness (N Engl J Med. 1998;338:1405-1412; J Pediatr. 2000;136:168-175), and modeling studies suggest that administering influenza vaccine to 70% of preschool and school-aged children would be highly likely to prevent communitywide epidemics (Vaccine. 2000;18:1902-1909). Other studies have indicated that influenza vaccine could be cost-effective in school-aged children in the United States (Pediatrics. 1999;103:1273. Abstract).
      Large, long-term trials are under way in Texas to determine whether vaccinating 85% of schoolchildren and 50% of preschool children who are 18 months of age or older with a cold-adapted, live attenuated vaccine can control the spread of influenza. According to Paul Glezen, MD, of Baylor College of Medicine in Houston, about 9500 children have received the influenza vaccine, and safety data are good.
      According to Dr. Reichert and associates, the findings of their study, together with the results of ongoing studies, warrant a reconsideration of current recommendations for the use of inactivated and live attenuated influenza vaccines, to encourage use of these vaccines in infants, children, and adults. Specific consideration of the vaccination of schoolchildren in pandemic planning is also warranted.

Return to top

 


When the program of immunizing Japanese schoolchildren was discontinued in 1994, excess mortality rates rose rapidly.

 

 


www.vaccinebulletin.com | VACCINE BULLETIN® 145 | May 2001 | Spotlight

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.